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ABSTRACT Candida glabrata is an important fungal pathogen which develops rapid antifungal resistance in
treated patients. It is known that azole treatments lead to antifungal resistance in this fungal species and that
multidrug efﬂux transporters are involved in this process. Speciﬁc mutations in the transcriptional regulator PDR1
result in upregulation of the transporters. In addition, we showed that the PDR1mutations can contribute to enhance
virulence in animal models. In this study, we were interested to compare genomes of two speciﬁcC. glabrata-related
isolates, one of which was azole susceptible (DSY562) while the other was azole resistant (DSY565). DSY565 con-
tained a PDR1 mutation (L280F) and was isolated after a time-lapse of 50 d of azole therapy. We expected that
genome comparisons between both isolates could reveal additional mutations reﬂecting host adaptation or even
additional resistance mechanisms. The PacBio technology used here yielded 14 major contigs (sizes 0.18–1.6 Mb)
and mitochondrial genomes from both DSY562 and DSY565 isolates that were highly similar to each other. Com-
parisons of the clinical genomes with the published CBS138 genome indicated important genome rearrangements,
but not between the clinical strains. Among the unique features, several retrotransposons were identiﬁed in the
genomes of the investigated clinical isolates. DSY562 and DSY565 each contained a large set of adhesin-like genes
(101 and 107, respectively), which exceed by far the number of reported adhesins (63) in the CBS138 genome.
Comparison between DSY562 and DSY565 yielded 17 nonsynonymous SNPs (among which the was the expected
PDR1 mutation) as well as small size indels in coding regions (11) but mainly in adhesin-like genes. The genomes
contained a DNAmismatch repair allele ofMSH2 known to be involved in the so-called hyper-mutator phenotype of
this yeast species and the number of accumulated mutations between both clinical isolates is consistent with the
presence of aMSH2 defect. In conclusion, this study is the ﬁrst to compare genomes ofC. glabrata sequential clinical
isolates using the PacBio technology as an approach. The genomes of these isolates taken in the same patient at two
different time points exhibited limited variations, even if submitted to the host pressure.
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Infectious diseases caused by fungal pathogens represent a major threat
to human health. It is estimated that 2 billion people suffer from
several forms of fungal diseases worldwide, from which 1.5 million
deaths will occur every year (Brown et al. 2012). Invasive fungal infec-
tions cause on average 50% mortality, with total number of deaths
comparable to tuberculosis and malaria (Brown et al. 2012). The most
problematic fungal pathogens include Candida, Aspergillus, and Cryp-
tococcus species (Richardson and Lass-Flörl 2008). Within Candida
species, Candida albicans and C. glabrata are known as the most-
recovered species from infected patients (Marchetti et al. 2004). The
current reports on the epidemiology of fungal diseases and their asso-
ciated impact on human health reﬂect that the available therapeutic
options, which include antifungal drugs, have limited efﬁcacy. Only
fourmajor classes of antifungal drug are used to treat patients including
azoles, polyenes, echinocandins, and pyrimidine analogs. Each of these
agents have speciﬁc cellular targets and are used in several formulations
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with different derivatives (Ruhnke 2014). In general, most Candida
species are susceptible to these drugs in vitro.
However, the use of antifungal agents has resulted in the inevitable
occurrence of antifungal resistance. Antifungal resistance in a speciﬁc
fungal isolate can be deﬁned as a lack of activity of a given drug at
concentrations that are higher than in a wild-type isolate. Antifungal
resistance has been reported for virtually all existing antifungal agents
and major fungal pathogens (Perlin et al. 2015). Frequencies at which
antifungal resistance occur in hospitalized patients are variable based
on data collected by population-based surveillance programs and avail-
able for major fungal pathogens including C. albicans and C. glabrata.
In general, antifungal resistance rates for C. albicans are low. In a study
performed between 2008 and 2011, resistance to ﬂuconazole (cut-
off: $64 mg/ml) or echinocandins (cut-off: $4 mg/ml) ranged from
between 1 and 2% in bloodstream isolates (Cleveland et al. 2012). Re-
sistance rates in C. glabrata are much higher: C. glabrata infections as
a cause of invasive candidiasis increased from 18% of all BSI isolates
in 1992–2001 to 25% in 2001–2007. Fluconazole resistance rates in
C. glabrata increased from 9 to 14% in the same time period (cut-
off: $64 mg/ml) (Pfaller et al. 2003, 2009). Resistance of C. glabrata
to the class of echinocandins is also increasing: within a 10-yr period
(2001–2010) in a US hospital, the echinocandin resistance rate in-
creased from 4.9 to 12.3% (Alexander et al. 2013). Similar trends are
documented in Europe, however resistance rates are reported to be
between 1 and 4% (Arendrup and Perlin 2014).
Recent studies have also documented the occurrence of multidrug
resistance not only inC. albicans but also inC. glabrata (Sanglard 2016).
C. glabrata cross-resistance between azoles and candins has captured
more attention recently (Perlin 2015). For example, among echinocan-
din-resistant isolates sampled between 2008 and 2013 in two US sur-
veillance hospital sites, 36% were also resistant to azoles (Pham et al.
2014). Between 2005 and 2013 in another US site, 10.3% C. glabrata
isolates from cancer patients were resistant to caspofungin, fromwhich
60% were cross-resistant to azoles (Farmakiotis et al. 2014). Intrigu-
ingly, the later study reported that caspofungin exposure alone could
induce multidrug resistance without azole exposure. While C. glabrata
azole resistance is mediated principally by efﬂux-dependent mecha-
nisms, candin resistance is the consequence of mutations in the genes
(FKS1 and FKS2) encoding the candin target enzyme (b-glucan syn-
thase) (Perlin 2015; Vale-Silva and Sanglard 2015). It has been shown
recently thatC. glabrata can exhibit highmutation rates in the presence
of antifungal agents. This property is based on the decreased activity of
the DNA repair machinery that exists in speciﬁc clinical isolates
(Healey et al. 2016b).
We have shown in the past years that C. glabrata azole resistance is
coupled with selective ﬁtness advantages in animal models of infection
(Ferrari et al. 2009; Vale-Silva et al. 2013). Speciﬁc isolates exhibit
upregulation of the adhesin EPA1 when the transcriptional activator
responsible for azole resistance CgPDR1 is mutated. When EPA1 is
upregulated, the consequence is that C. glabrata exhibits increased
adherence to host cells, which is one of the factors that contributes to
enhance virulence of this yeast species which develops azole resistance
(Vale-Silva et al. 2016). Our recent data also highlighted thatC. glabrata
can exhibit different degrees of adhesion to host cells. Given that adhe-
sins are implicated in this process, it becomes relevant to address the
repertoire of adhesins in speciﬁc C. glabrata lineages. Genome data are
critical to achieve this goal, however the only available C. glabrata
genome is up to now from the isolate CBS138 (Dujon et al. 2004). It
is estimated that C. glabrata contains 63 ORFs with adhesin properties
(de Groot et al. 2013). In a recent study, we compared CBS138 to other
clinical isolates and found that a speciﬁc isolate (DSY562) exhibited the
much higher adherence capacities to epithelial cells as compared with
CBS138. This result was not dependent on EPA1 expression since
DSY562 expressed EPA1 at much lower levels than CBS138.
These results stimulated our interest into the acquisition of the
DSY562 genome. At the same time, it became also pertinent to compare
the genome of this isolate with one (DSY565) that acquired azole
resistance within a time-lapse of 50 d from DSY562 in a patient with
oropharyngeal candidiasis (Sanglard et al. 1999). In this way, evolu-
tionary pressure on the derived isolate could be estimated at the level of
genome differences.
Here we report genome sequences from both related isolates. We
used several approaches to resolve the genome with high accuracy. We
analyzed the occurrence of polymorphisms between the two strains and
also addressed the repertoire of genes encoding adhesins.
MATERIALS AND METHODS
Strains and media
StrainsDSY562 andDSY565were reported earlier (Sanglard et al. 1999)
and were grown in YEPD at 30 under constant agitation.
DNA isolation
Genomic DNA from DSY5652 and DSY565 was obtained by the
spheroplasting method as previously described (Calabrese et al. 2000).
Multilocus sequence typing
Multilocus sequence typing (MLST) was performed according to the
study of Dodgson et al. (2003). Sequencing data of individual loci were
analyzed using an online web tool (http://cglabrata.mlst.net) to deter-
mine the sequence type (ST).
Genome sequencing
To produce high-quality genomic DNA from C. glabrata isolates, over-
night cultures (5ml) were ﬁrst grown in YNBminimal medium [0.67%
yeast nitrogen base (Dicfo) with 2% glucose] at 30 under constant
shaking to obtain 2 · 108 cells for each strain. The DNA isolation
protocol followed instructions of the Gentra Puregene Yeast/Bact kit
(Qiagen) with slight modiﬁcations. First, yeast cell lysis was performed
with Zymolyase 100T (3mg/ml end concentration) for 30min at 37. In
addition, after RNAse A treatment of precipitated nucleic acids,
phenol/chloroform extractions were carried out according to recommen-
dations issued by Paciﬁc Bioscience (PacBio SampleNet—Shared
Protocol) for the use of phenol/chloroform/isoamyl alcohol. After ﬁnal
precipitation with NH4OAc and several washes with 80% alcohol, the
genomic DNA was dissolved carefully in a small volume of elution
buffer (10 mM Tris-HCl, pH 8.5). Aliquots of 5 mg of extracted,
high-quality genomic DNA was diluted to 150 ml using elution buffer
at 30 mg/ml. Long insert SMRTbell template libraries were prepared
(20-kbp insert size) according to PacBio protocols. In total, nine SMRT
cells per strain were sequenced using P4 and P5 polymerase binding
and C2 and C3 sequencing kits with 120min (ﬁve ﬁrst SMRT cells) and
180 min acquisition on PacBio RSII. De novo genome assemblies were
produced using PacBio’s SMRT Portal (v2.0.0) and the hierarchical
genome assembly process (HGAP version 3.0), with default settings
and a seed read cut-off length of 6000 bp.
Illumina-basedgenomesequencingwasperformedbyFASTERISSA
(Plan-les-Ouates, Switzerland). Brieﬂy, 4 mg of each DSY562 and
DSY565 genomic DNA was fragmented by nebulization and the geno-
mic libraries were prepared following the procedure described in the
Genomic DNA Sample Prep Kit (Illumina, FC-102-1003). To obtain
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inserts of 300 bp, a size selection was performed on agarose gel before a
10-cycle PCR ampliﬁcation. The resulting libraries were sequenced in a
2 · 38-bp run on a Genome Analyzer IIx using the Sequencing Kit v4
(Illumina).
Genome comparisons
TheﬁnalPacBioassembliesofDSY562andDSY565wereanalyzedusing
Geneious (9.1.8). Genome comparisons were performed on the basis of
each chromosome’s homolog using the Mauve aligner plug in (pro-
gressive Mauve algorithm) (Darling et al. 2004). The alignments were
next inspected with a SNP discovery tool integrated in the software.
For comparisons between CBS138 and the Illumina-based genome
sequencing of DSY562 and DSY565, reads were imported in the CLC
genomic workbench software (v.9.5.2) (Qiagen). Variant detection was
performed from themapped reads using both probabilistic and quality-
based variant detection tools available in CLC.A pipeline of the analysis
of genome data are included in Supplemental Material, Figure S4.
RNAseq
RNAextractions from theC. glabrata strainsDSY562 andDSY565were
carried out as previously published (Ferrari et al. 2011). The strains
were grown to logarithmic phase in 5 ml YEPD medium [1% Bacto
peptone (Difco), 0.5% yeast extract (Difco), 2% glucose (Fluka)] at 30
under constant shaking. RNA libraries for RNAseq were prepared with
a TruSeq Stranded Total RNA Library Prep Kit (Illumina). The result-
ing libraries were processed using the Illumina TruSeq PE cluster kit v3
reagents and sequenced on the Illumina HiSequation 2500 system us-
ing TruSeq SBS Kit v3 reagents. Sequencing data were processed using
Illumina Pipeline software version 1.82 to obtain fastq ﬁles.
Sanger sequencing
Sequencing reactions were carried with a BigDye Terminator DNA
SequencingKit (Thermo Fisher Scientiﬁc,Waltham,MA) and analyzed
with a 3130XL genetic analyzer (Applied Biosystems). Primers used
are listed in Table S1. Forward and reverse tag primer tails (59-
CGACGCCCGCTGATA-39 and 59-GTCCGGGAGCCATG-39) were
added to each primer pair (labeled by sufﬁxes “-R” and “-F”). PCR were
performed on DSY562 andDSY565DNAwith the forward and reverse
primers which was followed by sequencing with the tag primers.
Adhesins predictions
DSY562 ORFs were analyzed with the help of the software FungalRV
(http://fungalrv.igib.res.in/index.html), which helps to predict the oc-
currence of adhesin-like proteins in fungal genomes. To select for
potential adhesins, a value of 0.5 was set as a threshold, as recom-
mended (Chaudhuri et al. 2011). The list of potential adhesins was
further subjected to several additional tests including a search for
PFAM domains (http://pfam.xfam.org/search#tabview=tab1) and the
presence of speciﬁc signatures relevant to the detection of adhesin-like
proteins. These signature included (i) the presence of signal peptides
and absence of internal transmembrane domains using the online pro-
grams SignalP and TMHMM (http://www.cbs.dtu.dk/services/); (ii) the
presence of consensus sequence for GPI anchor ([NSGDAC] – [GAS-
VIETKDLF] – [GASV] – X(4,19) – [FILMVAGPSTCYWNQ](10).),
as recommended by Weig et al. (2004); (iii) the presence of AWP motifs
(VSHITT) (deGroot et al. 2013); (iv) the presence of EPAmotifs (EPACC:
CX(27)CX(40)CX(44)DDX(13)CC) and EPA: GCSX(8,9)GL) following
Diderrich et al. (2015) and Gabaldón et al. (2013); and (v) the presence
of PIR motifs (Q[IV]XDGQ[IVP]Q) following (de Groot et al. 2008).
Protein alignments
Protein alignments were performed with aWeb tool available at http://
mafft.cbrc.jp/alignment/server (MAFFT version 7) and default settings.
A phylogenetic tree was constructed from the alignment produced
from the tool. The produced alignments were next visualized after
average linkage (UPGMA) and a bootstrapping with 1000 resamplings.
Detection of splicing junctions
RNAseq data obtained from DSY562 and DSY565 were imported as
fastq ﬁles into Geneious (9.1.8). Splice junctions were detected using the
TopHat RNAseq aligner (Trapnell et al. 2009).
Counterclamped homogeneous electric ﬁeld
(CHEF) analysis
Twoor threecoloniesof eachyeast strainwere inoculated inYEPDliquid
medium and incubated overnight at 30 with agitation. A culture vol-
ume corresponding to 109 cells was pelleted at 3000 · g for 5 min, and
cells were washed in 5 ml 50 mM EDTA (pH 9). The pellet was resus-
pended in 330 ml 50 mM EDTA. Next, 110 ml of SCE [1 M sorbitol,
n Table 1 Characteristics of DSY562 and DSY565
C. glabrata Clinical Strains ST
MIC (mg/ml)
PDR1 Mutation Time Elapsed (d)Fluconazole Voriconazole Amphotericin B
DSY562 ST8 4 0.25 0.5 — —
DSY565 ST8 64 1 0.5 L280F 50
ST, sequence type.
n Table 2 PacBio sequencing analysis of DSY562 and DSY565
PacBio
Strain/assembly type DSY562 DSY565 CBS138
SMRT cells 9 (8 P4C2 + 1 P5C3) 9 (8 P4C2 + 1 P5C3) —
Number of bases (Gb) 3.4 (coverage: 261·) 2.8 (coverage: 215·) —
Mean read length (kb) 6.5 5.7 —
Major contigs
(including mitochondrial DNA)
14 15 14
Minor contigs (4–20 kb) 5 9 —
Total of assembled bases 12,729,188 12,728,164 12,338,305
Mitochondrial genome 20,086 20,086 20,063
N50 1,178,607 1,064,616 —
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10 mM EDTA, 100 mM sodium citrate (pH 5.8), adjusted with citric
acid] was added and then completed with 5% b-mercaptoethanol and
Zymolyase 100T (100 units/ml) (solution I). The solution was gently
mixed with 560 ml of GTG agarose and rapidly distributed into molds
of 10 by 5 by 2 mm. The solidiﬁed plugs were immersed in solution II
[450 mM EDTA, 10 mM Tris-HCl (pH 8), 7.5% b-mercaptoethanol]
and incubated overnight at 37 without agitation. Solution II was
replaced by solution III [450 mM EDTA, 10 mM Tris-HCl (pH 8),
1% N-lauryl- Sarkosyl, and 150 mg/ml proteinase K]. Plugs were in-
cubated for 6 hr at 65 without agitation and kept for 10 min on ice.
Finally, plugs were transferred to a 0.5 M EDTA (pH 9) solution and
stored at 4 for several months. One-third of the plug was loaded into
wells of 0.6% GTG agarose gel in 0.5% Tris-borate-EDTA. The gel was
then placed into the electrophoresis chamber of a CHEF DR II (Bio-
Rad, Zürich, Switzerland) apparatus. Migration was performed in 0.5%
Tris-borate-EDTA at 14 with the following steps: block 1, 60- to 120-
min switch, 6 V/cm, and 120 over 24 hr; block 2, 120- to 300-min
switch, 4.5 V/cm, and 120 over 22 hr. After gel electrophoresis, gels
were stained with ethidium bromide to reveal DNA under ultraviolet
light.
n Table 3 Details of PacBio assembly of DSY562 and DSY565
DSY562 Length (bp) DSY565 Length (bp)
Chr A 482,027 Chr A 482,027
Chr B 511,306 Chr B 511,306
Chr C 646,952 Chr C 628,526
Chr D-L 695,320 Chr D-L 695,913
Chr E 711,760 Chr E 712,009
Chr F-L-I 1,594,519 Chr F-L-I 1,594,552
Chr G 1,026,668 Chr G 1,009,061
Chr H 1,064,558 Chr H 1,064,559
Chr I-L-D 752,897 Chr I-L-D 744,977
Chr J 1,234,082 Chr J1 1,048,338
Chr J2 181,774
Chr K 1,305,194 Chr K 1,305,194
Chr L 1,178,610 Chr L 1,176,450
Chr M-J 1,424,660 Chr M-J 1,419,287
Mitochondrial DNA 20,086 Mitochondrial DNA 20,086
Total Chr + mitochondrial DNA 12,648,639 12,594,059
unitig13_20kb 20,067 unitig5_7kb 7847
unitig5_14kb 14,784 unitig6_11kb 11,645
unitig2_20Kb 23,113 unitig12_22kb 22,969
unitig20_10kb 10,815 unitig16_17kb 17,373
unitig16_11kb 11,770 unitig17_9kb 9902
unitig18_13kb 13,680
unitig20_14kb 14,791
unitig22_16kb 16,821
unitig32_19kb 19,077
Total small contigs 80,549 Total small contigs 134,105
Total all contigs 12,729,188 12,728,164
Figure 1 Chromosome structures of DSY562 as compared to CBS138. A circular map representing the major translocations between the CBS138
and DSY562 genomes was produced using J-Circos v2 (An et al. 2015).
2416 | L. Vale-Silva et al.
Data availability
Strains described here are available upon request. PacBio assemblies are
available under Bioproject PRJNA374542 (SRR5298594–SRR5298602
for DSY565, SRR5298595 and SRR5298512–SRR5298519 for DSY562).
RNAseq data are available under Bioproject PRJNA374632
(SRR5296197–SRR5296202). Paired-end reads from Illumina-based
genome sequencing are available under Bioproject PRJNA374542
(SRR5459192–SRR5459193). The ﬁnal assembled genomes for
DSY562 and DSY565 and their annotations are available under acces-
sion numbers MVOE00000000 and MVOF00000000, respectively.
RESULTS
Genome data acquisition
C. glabrata DSY562 and DSY565 are paired clinical isolates that were
isolated from an HIV-positive patient presenting oropharyngeal can-
didiasis. DSY565 was isolated after 50 d of ﬂuconazole therapy and
exhibited azole resistance (Sanglard et al. 1999) (Table 1). The relation-
ship between the two isolates was assessed at this time by RFLP which
concluded a high relationship between the isolates. Before undertaking
genome sequencing, both isolates were subjected to MLST typing
according to Dodgson et al. (2005) (Table 1), and thus the high re-
lationship between both isolates was conﬁrmed.
Genome sequencing was ﬁrst approached by Illumina HiSequation
38-bp, paired-end sequencing. Brieﬂy, trimmed reads of both DSY5652
andDSY565 were aligned to the reference genome of CBS138 using the
software CLC Genomics Workbench. In both cases, 95% of reads
aligned to the CBS genomes and coverage was 72- to 64-fold for
DSY562 and DSY565 data, respectively. Details on comparisons can
be found in File S1 and File S2. Both comparisons yielded a high
number of changes (85,711–85,986 including SNPs and indels) and
resulted in 10,390 nonsynonymous changes as compared to
CBS138. Given that the genomes were aligned and compared directly
toCBS138, they did not reﬂect actual genome rearrangements of strains
DSY562 and DSY565. We therefore undertook an alternative genome-
sequencing approach using PacBio technologies enabling de novo as-
sembly of large reads. Since this technology is prone to random intrinsic
high error rates, we aimed to reach genome sequencing coverage be-
tween 200- and 300-fold, which therefore required the use of several
sequencing SMRT cells. The PacBio data are summarized in Table 2. As
summarized in this table, the number of major assembled contigs
(size .20 kb) were 14 and 15 for DSY562 and DSY565, respectively.
N50s were 1.06 and 1.17 Mb for both isolates, thus highlighting the
high quality of the assemblies. Table 3 summarizes the sums of nucle-
otides for each assembled contig, which were assigned to chromosomes
according to the current CBS138 genome data (see below). DSY562 and
DSY565 accounted for totals of 12,729,188 and 12,728,164 nucleotides.
This represents a difference of 1024 nucleotides between the two ge-
nomes. The difference in nucleotide counts for major contigs (includ-
ing mitochondrial DNA) is larger (58,400 nucleotides), however this is
compensated for by nucleotide counts of the small contigs which could
not be consistently assembled to larger contigs.
Genome comparisons between clinical strains
and CBS138
Assembled contigs almost reconstituted the entire set of chromosomes
that is known from the CBS138 genome. Figure 1 shows the chromo-
some maps of DSY562 as compared to CBS138 as well as a circular
map to highlight major translocations between the reference and the
DSY562 genomes. For practical reasons, the naming of chromosomes
(A to M) was kept as proposed initially for CBS138. The data highlightn
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several chromosomal rearrangements between the two isolates. While
Chr A, B, E, G, H, and K kept similar structures between both strains,
other chromosomes underwent several modiﬁcations. Chr C, D, J,
and M in DSY562 underwent exchanges from CBS138 chromosomes
essentially at chromosomal extremities. Parts of Chr L and I were added
to Chr F (which was renamed as Chr F-L-I) in DSY562, thus yielding
the largest chromosome in this species (1.59 Mb). Chr D and L were
joined to the shortened Chr I (which was renamed as Chr I-L-D). The
left arms of Chr L and C were inverted as compared to CBS138. Re-
markably, the separate DSY565 assembly yielded the same chromo-
some arrangement as DSY562, with the exception that Chr J was not
completely assembled in DSY565. This chromosome was still split in
two parts (Chr J1 and J2; see Table 4 and Figure S1) in DSY565. A
CHEF was performed with strains CBS138 and DSY562/DSY565 to
compare these assemblies with physical chromosome separations. Re-
markably, size predictions from the assemblies corresponded well to
physical separations (see Figure 2). Red arrows shown in Figure 2
correspond to size conservation of Chr A, B, G, H, and J between the
two strains, which is consistent with predictions. Chr C, D, E, and F-L-I
were shifted to higher sizes (yellow color) by CHEF inDSY562, which is
also consistent with assembly predictions. Chr M and I-L-D exhibited
decreased sizes (blue color) as compared to CBS138, which is also
predicted from assemblies. Chr K from DSY562 showed a discrepancy
from the expected patterns from CBS138, however this result may be
due to intrinsic chromosome size variations observed by others for this
type of strain (Bader et al. 2012).
With these data, we ﬁrst compared the DSY562 PacBio-assembled
data (DSY562-HGAP3) with the CBS138 published genome (CGD,
version_s02-m04-r02). The DSY562-HGAP3 genome was ﬁrst anno-
tated with the tools available in the software Geneious (version 9.1.8,
“live-annotation” tool) with a threshold level of 95% between compar-
isons. DSY562-HGAP3 was also further annotated on the basis of a
recently published annotation using CBS138 and RNAseq data (Linde
et al. 2015). As observed from Table 4, the number of deduced CDS
(locus tag preﬁx B1J91) in DSY562 was 5294, which was near to the
5293 predicted CDS from CBS138. The DSY565 genome was next
annotated on the basis of DSY562 annotations with the same Geneious
tool and yielded 5298 CDS (locus tag preﬁx B1J92). Table 4 indicates
that the number of CDS in mitochondrial DNA and numbers of tRNA
were identical between strains. rDNAs were identiﬁed in DSY562 and
DSY565, and were located at the telomeric ends of Chr L andM-J as in
CBS138.
The similarity between the total number of CDS in the three strains
(5293–5298 CDS) obscures, however, the following divergence: when
comparing the CDS of each isolate, only a total of 5225 CDS were
shared between them. 65 CDS from CBS138 were not detected in
DSY562 and DSY565 (Figure 3 and File S3). 78 CDS from DSY562
and DSY565 were not found in CBS138. From these 78 CDS, 61 were
common to DSY562 and DSY565; thus highlighting unique CDS for
each of the strains. These above-mentioned results suggest that several
selection events resulted in the loss and gain of several genes between
these strains. When inspecting the identity of these 61 genes, we found
that most of the genes gained in DSY562 and DSY565 as compared to
CBS138 belonged to adhesin-like genes (34). Nine genes originating
from DSY562 and DSY565 (named here Tkp5-1 to -9) were most
similar to the Tkp5 protein from Vanderwaltozyma polyspora. This
type of protein encodes elements of Ty-like retrotransposons (see Dis-
cussion). Other common genes between DSY strains underwent dupli-
cation events, including B1J91/B1J92_D02794g (endoplasmic
reticulum membrane protein), B1J91/B1J92_M05115g (a putative ret-
rotransposon protein), B1J91/B1J92_H04257g, and B1J91/
B1J92_H04279g (encoding copper metallothionein MT-II and
MT-IIB in DSY562 and DSY565 respectively). Interestingly, B1J91/
B1J92_H04257g and B1J91/B1J92_H04279g were found in four
Figure 2 CHEF chromosome
separations of isolates CBS138,
DSY562, and DSY565. Chromo-
some sizes are indicated for
CBS138 and were extracted
from public databases. Colored
/’s show the size changes be-
tween the CBS and DSY562/
DSY565 genomes. Red, yellow,
and blue colors signify size
conservation, increased sizes,
and decreased sizes between
CBS138 and the two different
genomes, respectively. The at-
tached table lists the chro-
mosome sizes deduced from
genome data of CBS138 and
DSY562/DSY565. Plotting the
relative migration distance (Rf
values) of known CBS138 chro-
mosome sizes with the obtained
sizes of DSY562 and DSY565
chromosomes yielded an R2
value of 0.981.
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tandem repeats on Chr H as opposed to CBS138, in which only one
repeat is found. The remaining 10 genes out of the 61 common to
DSY562 and DSY565 were ranked as pseudogenes in the current
CGD (some of which are also described as adhesin-like genes), thus
explaining their absence from the CBS genome used in our analysis.
Genes that were CBS138 speciﬁc (65) included, among others, adhesin-
like genes (6), CAGL0B01243g (MATa1), and CAGL0G07175g (RNA
binding protein with RNA-directed DNA polymerase activity). Nota-
bly,MATa1 is still present in DSY562 and DSY565 but as another CDS
(B1J91/B1J92_B00242g). Most of the remaining CBS138-speciﬁc genes
were of unknown function (48) (see details on File S3).
At the level of single nucleotides, large differences were observed
between DSY562 and CBS138 (Table 5). Nuclear and mitochondrial
genomes diverged by 0.7% between the two strains. These data indicate
extensive divergence between the two genomes, however they are in
general agreement with the analysis deduced from other C. glabrata
genomes (Singh-Babak et al. 2012). The high number of nonsynony-
mous SNPs (11,014) underscores a large number of amino acid sub-
stitutions. A high number of SNPs occurred in genes encoding
adhesins, and the following section will discuss the resolution of this
important gene category. A few genes underwent frameshifts resulting
in protein truncations. For example, B1J91/B1J92_D00154g (AQY1,
role in ion transport) was truncated in DSY562 and DSY565 (CDS
length of 459 bp) as compared to CBS138 (CDS length of 873 bp).
Interestingly, another homolog is present in DSY562 and DSY565
(B1J91/B1J92_A01221g), thus likely compensating for the probable loss
of function of B1J91/B1J92_D00154g. B1J91/B1J92_C02343g (ARB1: a
protein with ATPase activity and a role in cellular response to drugs, a
ribosomal small subunit exported from the nucleus and cytosol), which
contains an intron in CBS138, lacks a reading frame in DSY562 and
DSY565. Removal of the intron in this gene restores a truncated CDS as
compared to CBS138. B1J91/ B1J92_E01309g (EKI1: choline kinase
activity, a role in the phosphatidylcholine biosynthetic process)
exhibited an N-terminal deletion due to the use of other intron splicing
as compared to the CBS138 homolog. B1J91/B1J92_M05687g (NPY1:
has NAD+ diphosphatase activity and a role in the NADH metabolic
process), B1J91/B1J92_G03487g (TMN3: has a role in cellular copper
ion homeostasis), B1J91/B1J92_I10725g (YGR122W: has a role in neg-
ative regulation of transcription from the RNA polymerase II pro-
moter), B1J91/B1J92_E01155g (RPA14: RNA polymerase I activity),
and B1J91/B1J92_H06017g (FLR1: a multidrug transporter of the ma-
jor facilitator superfamily) exhibit N-terminal truncated proteins as
compared to CBS138. Whether the identiﬁed protein truncations
may result in deﬁcient functioning remains to be established. We be-
lieve that these changes do not reﬂect PacBio errors since (i) the
DSY562 and DSY565 assemblies were produced independently to pro-
duce the same changes as compared to CBS138, and (ii) Sanger se-
quencing veriﬁcations conﬁrmed the absence of PacBio errors [see
example of B1J91/B1J92_H06017g (FLR1) sequencing in Figure S2].
We also noticed that some previously annotated tandem CDS in
CBS138 were now forming a single CDS in DSY562. For example,
B1J91/B1J92_I02816g and B1J91/B1J92_I02838g (AZF1: asparagine-
rich zinc ﬁnger protein) were now generating a single CDS (B1J91/
B1J92_I02838g) in DSY562. B1J91/B1J92_E03421g and B1J91/
B1J92_E03432g (close homologs of Saccharomyces cerevisiae CDA1
and CDA2 genes; chitin deacetylases) were now forming a single
CDS (B1J91/B1J92_E03421g). It is interesting to observe that there
are370000 nt differences between the CBS138 and DSY562 genomes
(the latter having the largest genome), thus highlighting that additional/
novel genesmay be present in the DSY strains (see below). As a last step
in these comparisons, we analyzed the presence of introns in strains
DSY562 and DSY565 as compared to CBS138. This was performed
ﬁrst by the transfer of annotations from the recently updated
CBS138 genome. We next used RNAseq data from both DSY562
and DSY565 transcriptomes to detect spliced RNAs. Table 5 shows
that DSY562 and DSY565 genomes possessed at least 144 intron-
containing genes, which is close to the number identiﬁed in
CBS130 (150). RNAseq data from DSY562 and DSY565 showed
that 114 and 115 splice sites, respectively, coincided with the pre-
dicted splice sites (File S4).
The cluster of adhesins in DSY562
C. glabrata is known for its extensive repertoire of adhesins. The genes
encoding adhesins often contain repeated motifs and are mostly local-
ized at chromosome extremities. These two characteristics make it
challenging to establish a detailed and complete listing of adhesins from
C. glabrata genomes. Here we have used PacBio genome assembly
approaches to address these challenges and we used a systematic anal-
ysis (described inMaterials andMethods) to identify adhesin-like genes
in DSY562 and DS565. Brieﬂy, all DSY562 CDS were screened with the
help of the software FungalRV, which helps to predict the occurrence of
adhesin-like proteins in fungal genomes (Chaudhuri et al. 2011). We
next analyzed the list of potential adhesins for the occurrence of PFAM
Figure 3 Venn diagram representation of genes shared between
DSY562, DSY565, and CBS138. The diagram was generated with a
Web tool available at http://bioinformatics.psb.ugent.be/webtools/
Venn/.
n Table 5 Whole genome differences between DSY562 and CBS138
CBS138 vs. DSY562
Nonsynonymous SNP Synonymous SNP
In/Outside
SNPs Indels Indels
Total Percentage
SNP-Indel vs. CBS
Total 11,014 25,845 86,915 5353
Percentage vs. CBS 0.09 0.21 0.7 0.04 0.7
Mitochondrial 34 11 140 57
Percentage vs. CBS 0.17 0.055 0.7 0.285 0.7
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domains and the presence of speciﬁc signatures, including (i) the pres-
ence of signal peptides and absence of internal transmembrane do-
mains, (ii) the presence of a consensus sequence for GPI anchor, (iii)
the presence of AWP motifs (de Groot et al. 2013), (iv) the presence of
motifs typical for the class of EPA proteins following Diderrich et al.
(2015) and Gabaldón et al. (2013), (v) the presence of PIR motifs, and
lastly (vi) the occurrence of hyphally regulated cell wall proteins
(Hyphal_reg_CWP, IPR021031). For practical reasons and for com-
parison purposes with CBS138, we used the same CAGL0 gene naming
that is currently accepted for CBS138. When several highly similar
proteins were identiﬁed in DSY562, we add a numerical sufﬁx to them
(i.e., 1, 2, etc.). According to our analysis, we proposed a list of 101 adhe-
sin-like proteins inDSY562 (File S5 and File S6), whichwell exceeds the
number of deduced adhesins in CBS138 (66) according to de Groot
et al. (2013). Figure 4 shows the genomic localization of adhesins de-
tected in DSY562 as compared to CBS138. Notably, the repertoire of
adhesins in DSY565 is very similar to DSY562 (Figure S1, see below).
50% of the adhesin genes were located in DSY562, near to the telo-
meric ends (region of 50 kb down to chromosome ends) of the chro-
mosomes. One example of the expansion of adhesins in DSY562 is
given by the end of Chr C (Figure 4). The size difference between
Chr C between DSY562 and CBS138 may be explained by the tandem
arrangement of a group of four adhesins. The DSY562 potential adhe-
sins were aligned and a phylogenetic tree was assembled (Figure 5).
This treewasmergedwith conserved domain features andwith CBS138
protein homologs to, on the one hand, help distinguish between these
Figure 4 Arrangement of adhesin-like genes in C. glabrata CBS138 and DSY562. The position of adhesins is shown by red and blue /’s in
CBS138 and DSY562, respectively. Chr C ends of DSY562 and CBS138 were enlarged to highlight the positioning of adhesins in the two
genomes. Black/’s indicate the position of adhesins in CBS138 which were inversely located in the Chr C arm of DSY562. A group of three
tandemly arranged adhesins in CBS138 (orange/) is increased by one member in DSY562. This group of four adhesins is tandemly arranged
with a second group of four adhesins.
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proteins and, on the other hand, to better delineate extensions of pro-
tein families in DSY562. Several protein clusters (highlighted by colors
in Figure 5) were observed. Members of the EPA family (19) were well
discerned in this tree (blue color of Figure 5) and harbor typical signa-
tures of EPA adhesins, including a PA14 domain as well as EPA-
speciﬁc domains (see details inMaterial andMethods), with the exception
of B1J91_K00170g4. Duplication of speciﬁc EPAs occurred in DSY562
for EPA2, EPA6, EPA8, EPA12, and EPA22. The largest cluster of
proteins contained VSHITT-motif repeats and PA14 motifs, however,
they lacked EPA signatures (green color of Figure 5). CBS138 PWP
homologs (PWP1, -2, -3, and -5) were found in this cluster. VSHITT-
motif repeats were also found in another cluster (red color of Figure 5)
that essentially lacked PA14 motifs. The largest extension occurred for
adhesin-like proteins with VSHITT repeats that include members of
the PWP and AWP family (Figure 5). Another well-distinguished clus-
ter lacked bothVSHITT and PA14motifs and contained CBS138 AWP
homologs (AWP6 and -7). Only one gene (B1J91_M11726g) contained
a PIR motif and was extensively unrelated to other genes of the phy-
logenetic tree. The remaining proteins could not be assembled in clus-
ters with common features. Taken together, the data suggest that
61 novel adhesin-like proteins were assigned to DSY562, while
40 remained in common with CBS138 (Figure 5, only 50 adhesin-like
proteins without frameshifts were taken into account in these calcula-
tions). The majority of the novel proteins exhibited VSHITT domains.
Genome comparisons between DSY562 and DSY565
As we mentioned earlier, DSY5652 and DSY565 are two highly related
isolates that were obtained from a patient treated with ﬂuconazole for
oropharyngeal candidiasis. DSY565 was isolated 50 d after initiation
of ﬂuconazole treatment andwas azole resistant.We reported that azole
resistance was due to a mutation in the transcription factor CgPDR1.
Thismutation was contributing to an increase of virulence as compared
to a parental strain and was measured in different animal models
(Ferrari et al. 2009; Vale-Silva et al. 2016). Given that virulence traits
may be multifactorial, we reasoned that other mutations may contrib-
ute to this phenotype. Direct genome comparisons with PacBio-
generated data may provide some cues into this hypothesis. We ﬁrst
annotated the DSY562 genome to a high resolution as described above
and used this basis as a tool to annotate the DSY565 genome. The use of
CBS138 as an annotation basis provided similar results (data not
shown). Table 2, Table 3, and Table 4 compare several features between
DSY562 and DSY565. At the genomic level, a few changes occurred.
While 101 adhesin-like genes were identiﬁed in DSY562, 107 adhesin-
like genes were found in DSY565 (Figure S1). 95 adhesins were shared
between both isolates (Figure 6) and the discrepancies between the two
genomes were principally due to the presence of adhesin-like genes in
small contigs, which could not be mapped to the chromosomes (Figure
S1). 12 and three adhesin-like and unique genes were identiﬁed in the
small contigs of DSY565 and DSY562, respectively. In addition,
DSY562 possesses one gene (B1J91_E00110g1) located at the extremity
of Chr J that is not present in DSY565 (Chr J1). This may be due to
incomplete assembly of Chr J1 in this isolate. One other speciﬁc change
between DSY562 and DSY565 occurred at the left arm of Chr C. A size
difference of 29 kb exists at the left arm of Chr C between DSY562
and DSY565 (Figure S1). While a tandem repeat of B1J91_C01067g is
present in DSY562 at the Chr C extremity, only one copy remained in
DSY565. However, this gene is now situated between the adhesins
B1J92_C00968g1 and B1J91_C01133g1 of DSY565 (Figure 6). One
remaining copy of this speciﬁc adhesin (B1J92_C01067g1) is situated
in the small contig unitig16_17kb, which suggests that this small contig
Figure 5 Adhesins in DSY562. (A) Phylogenetic tree of DSY562 adhesin-like genes. Each gene is labeled with conserved PFAM functional
domains (see Materials and Methods). Adhesin clusters (I–VII) were those reported in de Groot et al. (2008). (B) Difference between DSY562 and
CBS138 adhesins.
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may be assigned to the missing nucleotides of the DSY565 Chr C
left arm.
Another major difference between DSY562 and DSY565 is that
DSY565 lacks the retrotransposon Tkp5-7 that is situated at the right
arm of Chr M in DSY562. Interestingly, DSY565 has retained a single
long terminal repeat (LTR) at this locus as a trace of the presence of the
retrotransposon. A PCR-based approach conﬁrmed the absence of
Tkp5-7 in DSY565 while leaving the LTR signature (see Figure S3).
At the single nucleotide level, differences between DSY562 and
DSY565 include synonymous and nonsynonymous SNP variations as
well as indels. Table 6 gives an overview of the observed differences.
First we noticed that most of the indels in these comparisons were in
homopolymeric sequences, which are long stretches (10–30) of identi-
cal nucleotides (108 in total). Since it is known that PacBio can yield
these differences, we undertook systematic veriﬁcations of these se-
quences by separate Sanger sequencing of small PCR fragments
Figure 6 Adhesin distribution between CBS138 and DSY strains. (A) Divergent position of adhesins between DSY565 and DSY562. The map was
created with the Mauve plug in available in the Geneious software. (B) Venn diagram representation of adhesins shared between CBS138,
DSY562, and DSY565 isolates. Venn diagram data can be found in File S6.
n Table 6 Nucleotide variations between DSY562 and DSY565
Chr name
DSY562 vs. DSY565
Nonsynonymous
SNP
Indels in
CDS
Synonymous
SNP
In/Outside
SNP Indels
Corrected Indels
in
Homopolymers
Chr A 2 0 0 3 0 4
Chr B 0 0 0 1 0 1
Chr C 1 1 0 3 1 4
Chr D-L 3 1 1 4 1 7
Chr E 2 2 2 4 0 8
Chr F-L-I 1 1 3 7 3 (2)a 17
Chr G 0 0 1 1 2 (1)a 9
Chr H 1 0 0 2 3 4
Chr I-L-D 3 3 1 6 0 4
Chr J1 0 1 2 5 3 3
Chr J2 0 1 1 0 0 1
Chr K 1 0 0 1 0 10
Chr L 0 1 0 9 0 4
Chr M-J 3 0 0 6 1 16
Mitochondrial
DNA
0 0 0 0 0 3
Total 17 11 11 52 14 95
a
Number in parentheses indicates the number of single nucleotide indels.
2422 | L. Vale-Silva et al.
comprising these putative indels. Only eight of these indels were
conﬁrmed by this approach (95 out of 108 were corrected; see Table
6 and File S7). Other indels in nonhomopolymeric sequences
(14 indels 2 8 indels in homopolymeric sequences = 6) were iden-
tiﬁed by genome comparisons between DSY562 and DSY565. Their
presence was conﬁrmed by separate genome alignment with Illu-
mina reads obtained in the early stage of the project (data not
shown). We also identiﬁed a number of indels within coding re-
gions that were also nonhomopolymeric. These variations between
the two strains ranged from three to a larger number of nucleotides,
however only a few of them created frameshifts (see Table 8).
A total of 17 nonsynonymous SNPs were identiﬁed between both
genomes (Table 7). As expected, the transcription factor CgPDR1
harbored the L280F substitution in DSY565. This mutation is known
to be sufﬁcient tomediate azole resistance inC. glabrata (Ferrari et al.
2009). The other nonsynonymous SNPs were located in genes
not known to be associated with drug resistance. Related with tran-
scription was the identiﬁcation of a nonsynonymous SNP in
B1J91_L0L01001g (NOT3: subunit of CCR4-NOT, a global transcrip-
tional regulator). Three other nonsynonymous SNPs were located in
genes involved in rRNA metabolism and ribosome biogenesis:
B1J91_H02057g (GAR1: nucleolar rRNA processing protein),
B1J91_M00946g (YLR435w: a protein with a potential role in pre-
rRNA processing), and B1J91_M08954g (YOR019w: a protein of
unknown function; may interact with ribosomes). We noticed several
genes containing nonsynonymous SNPs that annotated with trans-
porter functions, including B1J91_A01804g (HXT3/HXT1: hexose
transporter), B1J91_D02442g (LEM3: translocation of phospholipids
and alkylphosphocholine drugs), B1J91_K04565g (YGR065c: vita-
min H transporter), and B1J91_M13233g (MNR2: vacuolar
membrane protein; putative magnesium transporter). Two
other nonsynonymous SNPs were situated in adhesin genes
(B1J91_C00968g3 and B1J91_C00209g2). The question of whether
or not thesemutations result from speciﬁc selection pressure from the
host or from drug exposure cannot be answered yet; but either is
possible. Besides these nonsynonymous SNPs, larger deletions an
insertionswere identiﬁed in coding sequences (Table 8). Themajority
of these deletions/insertions (7 out of 11) were observed in adhe-
sin-like genes. We cannot presently exclude that these changes are
the results of PacBio read mis-assemblies. Some of the affected
CDS are located near to chromosome ends, which are known to be
recalcitrant to correct assembly and include repetitive sequences.
It is likely that recombination events in these regions may generate
variations which could result in a beneﬁcial phenotype for the
fungus.
DISCUSSION
We described here the genomes of two C. glabrata sequence isolates,
DSY562 and DSY565, originating from an HIV-positive patient with
oropharyngeal candidiasis. The close relationship between these two
isolates reported earlier (Sanglard et al. 1999) is conﬁrmed here by the
high level of similarity between the sequenced genomes. We showed
earlier that DSY565 contained a GOF mutation in PDR1 (L280F),
contributing to azole resistance but also enhancing virulence in an-
imal models. PDR1 GOF can modulate the expression of the adhesin
EPA1 and this effect results in increased adherence to host tissues.
Enhanced virulence due to PDR1 in DSY565may also be due to other
factors. On the other hand, we observed that DSY562, the parent of
DSY565, was intrinsically highly adherent to host cells, even with the
lowest EPA1 expression levels as compared to other tested strains.
This intrinsically high adherence capacity was observed with a PDR1n
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wild-type allele (Vale-Silva et al. 2016). Interestingly, a separate study
demonstrated that DSY562 was a C. glabrata isolate with the highest
capacity among those tested to bind C. albicans hyphae (Tati et al.
2016). Binding of C. glabrata involved the C. albicans Als3 adhesin.
All these data suggested the potential presence of other adhesins in the
genetic background of DSY562 and its related strain DSY565. Given
these reasons, we aimed here to obtain the two C. glabrata genomes
with a high resolution to identify all possible differences between the
two genomes and to determine all possible adhesin and adhesin-like
genes in the two genomes.
At the genomic level, DSY562 andDSY565underwent severalmajor
chromosomal rearrangements. No data are currently available on
PacBio-assembled C. glabrata genomes of sequential isolates, and it is
therefore difﬁcult to compare our results with other studies. One recent
short report described the genomes of three pairs of C. glabrata isolates
from patients with candidemia (Håvelsrud and Gaustad 2017). The
genomes were assembled de novo using Illumina reads, thus resulting
in different genome outputs (119–186 scaffolds). Comparison between
the DSY genomes and the three published pairs using the same chro-
mosomal fragments highlighted divergences as high as those between
DSY isolates and CBS138. This underlines the high genetic diversity
existing between C. glabrata isolates of different origins which has been
observed by others using different approaches. One other recent study
also applied Illumina-based de novo assembly of 33 genomes (Carreté
et al. 2017) which identiﬁed 17 different chromosome patterns. Some
patterns are similar to those observed in DSY562 and DSY565. While
Chr D-L and Chr L inversions, as well as Chr I-L-D are among the
common patterns, Chr F-L-I and Chr C inversions seem unique to
DSY562 and DSY565. Another separate study established the genome
of a C. glabrata isolate (CCTCCM202019) which is an industrial yeast
strain widely used to produce a-oxocarboxylic acid (Xu et al. 2016).
Genome data were established on the basis of a 150-bp, pair-end library
sequenced by Illumina approaches and 111 contigs and 74 scaffolds
were generated. Interestingly, this C. glabrata isolate was remarkably
closely related to CBS138 (205 SNP differences) (Xu et al. 2016).
Taken together, these studies underline the high genetic diversity
existing between C. glabrata isolates of different origins. It is likely that
future studies will reveal additional patterns. In proportion to the size of
their genomes, the number of changes between theDSY strains is rather
small. We noticed only 17 nonsynonymous changes between these
isolates (Table 7). Besides the known L280F change in PDR1, several
other proteins with diverse functions were affected. The role played by
these alterations is not clear at this time. One might speculate that they
could contribute to the ﬁtness of DSY565 or that they might be acci-
dental. Other larger changes were detected between both strains (Table
8) and they occurred mainly in adhesin-like genes. This could reﬂect
some adaptation due to host selection pressure.
It has been reported earlier that themismatch-repair geneMSH2 can
modulate drug resistance when its activity is compromised by speciﬁc
SNPs, giving rise to a hyper-mutator phenotype (Healey et al. 2016b).
Interestingly, DSY562 and DSY565 carry a V239L nonsynonymous
mutation in MSH2, which is known to favor this hyper-mutator phe-
notype (Healey et al. 2016b). One might expect that this phenotype
could generate genetic diversity within the context of host conditions.
DSY565 was isolated with a time-lapse of 50 d in the oral cavity of a
patient as compared to DSY562. Within this elapsed time, the MSH2
defect may lead to mutation accumulations. In a study probing the
accumulation of mutations due to MSH2 defects in S. cerevisiae over
170 generations in vitro, mutation rates (mutations per bp per gener-
ation) were in the range of 5–9 · 1028, which corresponded to 8–16
single base pair substitutions and 110–180 deletions/insertions in then
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haploid S. cerevisiae genome (Lang et al. 2013). The number of gener-
ations that occurred within the time-lapse of DSY562 and DSY565
isolation may correspond to at least 250–500 generations, when taking
into account 5–10 generations/d according to published data (Forche
et al. 2009; Roetzer et al. 2011). Taking into account the data of Table 7
and Table 8, the number of SNPs and indels between DSY562 and
DSY565 are in agreement with numbers reported in S. cerevisiae.
One may expect that in C. glabrata the MSH2 defect may generate
random mutations with a negative effect on in vivo ﬁtness. The host
conditions may serve as a selection pressure to eliminate progeny with
ﬁtness costs. We only sampled successful progenitors from the clinic,
which of course strongly reduces the diversity of isolates for further
analysis. This underpins that genetic diversity by theMSH2 defect may
be much higher than observed from the collected clinical strains. The
current literature on the effect of DNA mismatch-repair defects also
highlighted that the occurrence of mutations is not random: DNA
regions with a greater density of repeats are more mutable in mismatch-
repair defective cells (Ma et al. 2012; Lang et al. 2013). In the context
of adhesins, which are enriched in repetitive elements, MSH2 defects
may perhaps contribute to increase the diversity of this gene family
over generations. It has been observed that 44–50% of investigated
isolates (n = 625) were carrying MSH2 defects which thus indicates
that the MSH2 defect may confer some selective advantage in C.
glabrata (Dellière et al. 2016; Healey et al. 2016a,b). In agreement with
our hypothesis, it is interesting to mention that CBS138 and CCTCC
M202019 do not exhibit MSH2 defects and they contain a limited
repertoire of adhesins as compared to DSY562/DSY565.
Besides the above-mentioned SNPs, the DSY562 and DSY565
genomes harbored transposon-like genes not reported previously in
C. glabrata. These Ty-like retrotransposons genes (named here Tkp5-1
to -9) were most similar to the Tkp5 protein from V. polyspora, a yeast
representing the postwhole-genome duplication lineagemost divergent
from S. cerevisiae (Scannell et al. 2007).We observed that, while Tpk5-2
and Tpk5-5 to -9 encoded the same proteins, Tpk5-3 and -4 were
different (66% identity) but still similar to the Tkp5 protein from V.
polyspora. Tpk5-1 shared the C-terminal ends of Tpk5-3 and -4. As
expected from retrotransposons, Tpk5-2 and Tpk5-5 to -9 were ﬂanked
by the same LTRs, while Tpk5-3 and -4 were ﬂanked by other distinct
LTRs. Curiously, Tpk5-1 was located next to B1J91/B1J92_M05115g
on Chr G, which is described as similar to Ty5-6, a S. paradoxus retro-
transposon. Both genes are ﬂanked by the same LTR. Taken together,
these features suggest that DSY562 and DSY565 have acquired retro-
transposons from different sources and that these strains have under-
gone several transposition events. Notably, DSY565 did not retain
Tkp5-7, which is otherwise situated at the right arm of Chr M in
DSY562. Given that a single LTR remained at this location in
DSY565, this suggests an active transposition system. This retrotrans-
poson was not identiﬁed in another location in DSY565.
We determined the presence of .100 adhesin-like genes in both
DSY strains, which was not yet anticipated from other genome-wide
studies. This number exceeds by far the numbers published for CBS138
(50–66, depending on the criteria used for selection) and therefore
suggests that an expansion of this gene family occurred in our isolates.
A genome report on a separate C. glabrata isolate closely related to
CBS138 identiﬁed 49 adhesin-like genes (Xu et al. 2016). Since no
equivalent C. glabrata genome assembly has been yet published using
a PacBio approach, we still cannot conﬁrm whether or not the inves-
tigated isolates constitute a unique case or that a high repertoire of
adhesin genes (.100 genes) is shared in several C. glabrata clades.
The number of identiﬁed adhesins between both isolates differs sub-
stantially (101 in DSY562 vs. 107 in DSY565). It is unlikely that this
discrepancy could reﬂect an expansion of adhesins in DSY565 as com-
pared to DSY562 in such a short time-lapse between sampling of iso-
lates. We rather attribute this difference to technical issues during the
assembly of PacBio reads. These reads produced small contigs, as illus-
trated in Figure S1, which are enriched in adhesin genes. These genes
probably form part of chromosomal ends, but remain presently un-
assembled to major contigs.
To help distinguish the adhesins in DSY562 and DSY565, we used a
combination of hierarchical clustering and mapping of PFAM and
functional domains. With this approach, we could distinguish four
major groups including the EPA-like genes, two VSHIT-containing
groups, and another group with genes lacking EPA and VSHIT signa-
tures. This grouping is less complex thanproposed earlier usingCBS138
data (seven clusters) (de Groot et al. 2008). The overlay between both
grouping showed consistently that cluster I contained the EPA-like
genes and that clusters V and VII and clusters II and III were grouped
in two categories that include VSHIT-containing adhesins. The other
clusters (IV and VI) are located in distinct branches, the latter being
grouped in genes lacking EPA and VSHIT signatures. It is presently
difﬁcult to validate one or the other categorization, since no systematic
functional analysis of all adhesins has been yet carried out with the
exception of EPA-like genes (Zupancic et al. 2008). Now that a more
extensive repertoire of adhesins is available from our studies, such
analysis may be undertaken in the future.
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